| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ana Clara Aprotosoaie | Q89848828 |
| P2093 | author name string | Anca Miron | |
| Monica Hăncianu | |||
| Viviana Aursulesei | |||
| Irina-Iuliana Costache | |||
| Alexandru Dan Costache | |||
| P2860 | cites work | Pharmacogenomics knowledge for personalized medicine | Q24623166 |
| A regulatory science viewpoint on botanical-drug interactions | Q88496830 | ||
| Transporter-mediated natural product-drug interactions for the treatment of cardiovascular diseases | Q88496841 | ||
| Interaction of herbal products with prescribed medications: A systematic review and meta-analysis | Q91124963 | ||
| Safety of St John's wort (Hypericum perforatum) | Q93929858 | ||
| Fruit juice inhibition of uptake transport: a new type of food-drug interaction | Q24630998 | ||
| Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics | Q24656624 | ||
| Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q24678775 | ||
| Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin | Q24679132 | ||
| Grapefruit juice-drug interactions | Q24683430 | ||
| Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin | Q28142865 | ||
| Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients | Q28236175 | ||
| Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). | Q33507567 | ||
| Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers | Q33686542 | ||
| Interactions between herbs and conventional drugs: overview of the clinical data. | Q34124444 | ||
| Safety of herbal supplements: a guide for cardiologists | Q34126109 | ||
| Evaluation of metabolism-mediated herb-drug interactions | Q34238039 | ||
| Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review | Q34306204 | ||
| Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions | Q34360600 | ||
| Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. | Q34427980 | ||
| Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid | Q34467998 | ||
| Warfarin and its interactions with foods, herbs and other dietary supplements | Q34566453 | ||
| Effects of grapefruit juice and smoking on verapamil concentrations in steady state | Q34647627 | ||
| Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature | Q34723619 | ||
| No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers. | Q34819036 | ||
| Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren | Q34976482 | ||
| Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations | Q35009679 | ||
| Aliskiren: An orally active renin inhibitor | Q35013037 | ||
| Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily | Q35219649 | ||
| Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q35826093 | ||
| Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios | Q35860313 | ||
| Effects of treatment with a commercially available St John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin | Q36048039 | ||
| Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. | Q36303746 | ||
| Interaction of grapefruit juice and calcium channel blockers | Q36524627 | ||
| Apple juice greatly reduces systemic exposure to atenolol | Q36562479 | ||
| Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects | Q36842490 | ||
| Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer | Q37248856 | ||
| Updates on the clinical evidenced herb-warfarin interactions | Q37686931 | ||
| Effect of green tea catechins on the pharmacokinetics of digoxin in humans. | Q64954455 | ||
| Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin | Q70766724 | ||
| Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion | Q71123778 | ||
| Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics | Q72692410 | ||
| Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) | Q73145709 | ||
| Probable interaction between warfarin and ginseng | Q73166583 | ||
| Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients | Q73263247 | ||
| St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 | Q73443725 | ||
| Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity | Q73907168 | ||
| A taste of Chinese medicine! | Q77399253 | ||
| Subarachnoid haemorrhage associated with Ginkgo biloba | Q77506721 | ||
| Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations | Q77969100 | ||
| Grapefruit juice might still be factor in warfarin response | Q78049732 | ||
| Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol | Q80058660 | ||
| Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers | Q80237749 | ||
| Angiotensin II receptor blockers | Q81461133 | ||
| Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects | Q82718250 | ||
| Effects of curcumin on the pharmacokinetics of talinolol in human with ABCB1 polymorphism | Q84439697 | ||
| Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies | Q37807004 | ||
| Cardiac inotropes: current agents and future directions | Q37851240 | ||
| Pharmacokinetic considerations for digoxin in older people. | Q37902523 | ||
| The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification | Q38090328 | ||
| Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors. | Q38109095 | ||
| Pharmacokinetic drug interactions involving Ginkgo biloba | Q38122439 | ||
| The pharmacology of statins | Q38198397 | ||
| Warfarin interactions with medicinal herbs. | Q38252334 | ||
| Overview of green tea interaction with cardiovascular drugs | Q38259950 | ||
| Grapefruit Juice and Statins | Q38572006 | ||
| Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences | Q38574619 | ||
| An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic | Q38703024 | ||
| A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies | Q38737694 | ||
| Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy | Q38912037 | ||
| Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort? | Q38970017 | ||
| Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation | Q39023182 | ||
| Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters | Q39204093 | ||
| Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings | Q39245872 | ||
| Elevated international normalized ratio with the consumption of grapefruit and use of warfarin | Q39526215 | ||
| Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng | Q40877695 | ||
| Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng | Q41524465 | ||
| Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. | Q41813202 | ||
| Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren | Q42954978 | ||
| Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin | Q43830741 | ||
| Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions | Q44117767 | ||
| Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo | Q44139033 | ||
| Effect of soy milk on warfarin efficacy | Q44229933 | ||
| Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract | Q44899558 | ||
| Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin | Q44923001 | ||
| Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial | Q44967299 | ||
| Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers | Q45171973 | ||
| Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers | Q46091287 | ||
| Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers | Q46120062 | ||
| Reduced efficacy of rosuvastatin by St. John's Wort | Q46137737 | ||
| No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract | Q46459610 | ||
| Grapefruit juice ingestion significantly reduces talinolol bioavailability | Q46498387 | ||
| Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content | Q48090485 | ||
| Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects | Q50463845 | ||
| Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. | Q51465582 | ||
| Probable antagonism of warfarin by green tea. | Q53346088 | ||
| Update of green tea interactions with cardiovascular drugs and putative mechanisms | Q57398684 | ||
| Chinese herbs and warfarin potentiation by 'Danshen' | Q58210047 | ||
| Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review | Q60174195 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | herb-drug interactions | Q25326879 |
| P304 | page(s) | 9402781 | |
| P577 | publication date | 2019-09-02 | |
| P1433 | published in | Cardiovascular Therapeutics | Q1871490 |
| P1476 | title | Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products | |
| P478 | volume | 2019 |
| Q97524412 | A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs |
| Q100307409 | MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction |
Search more.